Improved MRI quantification of spinal cord atrophy in multiple sclerosis

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 3, 2014, Pages 617-623

  Kearney, Hugh ^a   Yiannakas, Marios C ^a   Abdel Aziz, Khaled ^a   Wheeler Kingshott, Claudia A M ^a   Altmann, Daniel R ^a,b   Ciccarelli, Olga ^a,c   Miller, David H ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

atrophy; MRI; multiple sclerosis; spinal cord

Indexed keywords

CONTRAST MEDIUM;

ADULT; ATROPHY; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; SPINAL CORD; THREE DIMENSIONAL IMAGING; TOTAL QUALITY MANAGEMENT;

ADULT; ATROPHY; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUALITY IMPROVEMENT; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPINAL CORD;

EID: 84894286217     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24194     Document Type: Article

References (30)

1. McDonald I, Compston A,. The symptoms and signs of multiple sclerosis. McAlpine's multiple sclerosis, 4th ed. London: Churchill Livingstone, Elsevier; 2006. p 287-342.
2. Fog T,. Topographical distribution of plaques in the spinal cord in multiple sclerosis. Arch Neurol Psychiatry 1950; 63: 382-414.
3. Oppenheimer DR,. The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol 1978; 4: 151-162.
4. Ganter P, Prince C, Esiri MM,. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 1999; 25: 459-467.
5. Lovas G, Szilágyi N, Majtényi K, et al. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123: 308-317.
6. DeLuca GC, Williams K, Evangelou N, et al. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 2006; 129: 1507-1516.
7. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632-2637.
8. Bot JC, Blezer EL, Kamphorst W, et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantative MR imaging findings to histopathologic results. Radiology 2004; 233: 531-540.
9. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy in multiple sclerosis: A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119: 701-708.
10. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
11. Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS,. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon β-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry 2003; 74: 1090-1094.
12. Kalkers NF, Barkhof F, Bergers E, van Schijndel R, Polman CH,. The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study. Mult Scler 2002; 8: 532-533.
13. Leary SM, Miller DH, Stevenson VL, Brex PA, Chard DT, Thompson AJ,. Interferon β-1a in primary progressive MS. Neurology 2003; 60: 44-51.
14. Montalban X, Sastre-Garriga J, Tintoré M, et al. A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis. Mult Scler 2009; 15: 1195-1205.
15. Rashid W, Davies GR, Chard DT, et al. Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J Neurol Neurosurg Psychiatry 2006: 77; 51-55.
16. Dietrich O, Reiser MF, Schoenberg SO,. Artifacts in 3-Tesla MRI: physical background and reduction strategies. Eur J Radiol 2008; 65: 29-35.
17. Vaithinanthar L, Tench CR, Morgan PS, Constantinescu CS,. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis. A quantitative T1 relaxation time mapping approach. J Neurol 2003; 250: 307-315.
18. Horsfield MA, Sala S, Neema M, et al. Rapid semi-automatic segmentation of the spinal cord from the magnetic resonance images: application in multiple sclerosis. Neuroimage 2010; 50: 446-455.
19. Rocca MA, Horsfield MA, Sala S, et al. A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology 2011; 76: 2096-2102.
20. Tench CR, Morgan PS, Constantinescu CS,. Measurement of cervical spinal cord cross-sectional area by MRI using edge detection and partial volume correction. J Magn Reson Imaging 2003; 18: 368-371.
21. Hou P, Hasan KM, Sitton CW, et al. Phase-sensitive T1 inversion recovery imaging: a time-efficient interleaved technique for improved tissue contrast in neuroimaging. AJNR Am J Neuroradiol 2005; 26: 1432-1438.
22. Bernstein MA, Thomasson DM, Perman WH,. Improved detectability in low signal-to-noise ratio magnetic resonance images by means of a phase-corrected real reconstruction. Med Phys 1989; 16: 813-817.
23. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
24. Reid JD,. Effects of flexion-extension movements of the head and spine upon the spinal cord and nerve roots. J Neurol Neurosurg Psychiatry 1960; 23: 214-221.
25. Healy BC, Arora A, Hayden MA, et al. Approaches to normalization of spinal cord volume: application to multiple sclerosis. J Neuroimaging 2012; 22: 12-19.
26. Lavdas E, Vlychou M, Arikidis N, Kapsalaki E, Roka V, Fezoulididis I,. Comparison of T1-weighted fast spin-echo and T1-weighted fluid-attenuated inversion recovery images of the lumbar spine at 3.0 Tesla. Acta. Radiol. 2010; 51: 290-295.
27. Kirkwood BR, Sterne JAC,. Essential medical statistics, 2nd ed. Oxford: Blackwell Science; 2003. p 364-365.
28. Bland JM, Altman DG,. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
29. Zivadinov R, Banas AC, Yella V, Abdelrahman N, Weinstock-Guttmann B, Dwyer MG,. Comparison of three methods for measurement of cervical cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol 2008; 29: 319-325.
30. Hickman SJ, Coulon O, Parker GJ, et al. Application of a B-spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three-dimensional MR images. J Magn Reson Imaging 2003; 18: 368-371.